Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Trimegah Bangun Persada Tbk. (NCKL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hetzer Medical Indonesia Tbk. vs Trimegah Bangun Persada Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume), while Trimegah Bangun Persada Tbk. trades at Rp925 (market cap 57.42T, 37.91M 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 503.4× Hetzer Medical Indonesia Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (37.91M versus 23.06M). Which is the better fit depends on your goals.
| MEDS | NCKL | |
|---|---|---|
Market Cap | 114.06B | 57.42T |
Volume | 23.06M | 37.91M |
Lot | 230.55K | 379.1K |
Turnover | 1.68B | 34.83B |
Average Price | 72.75 | 918.76 |
Value | 1.68B | 34.83B |
Indicative Equilibrium Price | 72 | 925 |
Indicative Equilibrium Volume | 1.56K | 10.28K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →About Trimegah Bangun Persada Tbk.
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →
